Discovery of nitazoxanide-based derivatives as autophagy activators for the treatment of Alzheimer's disease
Drug repurposing is an efficient strategy for new drug discovery. Our latest study found that nitazoxanide (NTZ), an approved anti-parasite drug, was an autophagy activator and could alleviate the symptom of Alzheimer's disease (AD). In order to further improve the efficacy and discover new che...
Saved in:
Main Authors: | Xiaokang Li (Author), Jian Lu (Author), Yixiang Xu (Author), Jiaying Wang (Author), Xiaoxia Qiu (Author), Lei Fan (Author), Baoli Li (Author), Wenwen Liu (Author), Fei Mao (Author), Jin Zhu (Author), Xu Shen (Author), Jian Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glyceraldehyde derivatives inspired by empagliflozin as potential anti-heart failure agents independent of glucose-lowering effects
by: Xiao Li, et al.
Published: (2024) -
Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
by: Long-fei Mao, et al.
Published: (2020) -
Sempervirine Mediates Autophagy and Apoptosis via the Akt/mTOR Signaling Pathways in Glioma Cells
by: Gaopan Li, et al.
Published: (2021) -
Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial.
by: Benjamin Speich, et al.
Published: (2012) -
Discovery of a small molecule inhibitor of cullin neddylation that triggers ER stress to induce autophagy
by: Yanan Li, et al.
Published: (2021)